Skip to Main Content
Beta test
our new site.
(
NLM Technical Bulletin
)
Home
Search
Study Topics
Glossary
Full Text View
Tabular View
No Study Results Posted
Related Studies
Analysis of Growth Factors in Patients Undergoing Lucentis or Avastin Injections for Diabetic Macular Edema and Exudative Macular Degeneration
This study is currently recruiting participants.
Verified June 2012
by Vitreo-Retinal Associates, Michigan
Study NCT01473251 Information provided by Vitreo-Retinal Associates, Michigan
First Received on November 14, 2011. Last Updated on June 19, 2012
History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Exudative Macular Degeneration
Diabetic Macular Edema
Additional conditions recognized in this trial
Edema
Macular Degeneration
Macular Edema
Wet Macular Degeneration
More general conditions related to this trial
Eye Diseases
Retinal Degeneration
Retinal Diseases
Signs and Symptoms
Interventions listed in this trial
Avastin
Lucentis
Additional drug interventions recognized in this trial
Bevacizumab
Mitogens
More general drug interventions related to this trial
Angiogenesis Inhibitors
Angiogenesis Modulating Agents
Antineoplastic Agents
Growth Inhibitors
Growth Substances
Mitosis Modulators
Molecular Mechanisms of Pharmacological Action
Pharmacologic Actions
Physiological Effects of Drugs
Therapeutic Uses
Sponsors listed in this trial
Vitreo-Retinal Associates, Michigan
Van Andel Research Institute
Back to top of Main Content